Jeffrey S. Heier, Chief Scientific Officer at Ocular Therapeutix, sold OCUL on Oct 2, 2026
Data as of Oct 16
▼ SELL$76.6K10,869 shares at $7.05Jeffrey S. Heier Chief Scientific OfficerOCUL Ocular Therapeutix, Inc
- Traded
- Oct 2, 2026
- Disclosed
- Oct 6, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
OCUL since disclosure
−6.4%
after the sale
Similar stocks (SPY) since disclosure
−2.0%
S&P 500 (SPY)
Change in closing price from Oct 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.